The APS Phenotyping Study
NCT06521502 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 4000
Last updated 2026-02-20
Summary
The goal of the observational APS phenotyping study is to better understand risk factors, potential biomarkers, length and severity of illness, and recovery for adults with ARDS, pneumonia, and/ or sepsis. This study will also generate a biobank of specimens collected from these patients that will be available to investigators for future studies of ARDS, sepsis, and/or pneumonia.
Conditions
Interventions
- OTHER
-
Blood collection
Blood will be collected from a catheter ("IV") that is already in place or using a needle stick into a vein. Blood will be collected in hospital (Cohorts A, B) and at visits 3 and 12 months following hospitalization for (Long-term Outcomes Cohort).
- OTHER
-
Urine Collection
Urine will be collected through a urinary catheter that is already in place or by urinating into a cup. Urine will be collected in hospital only (Cohorts A, B)
- OTHER
-
Nasal, oral, and rectal swabs
Nasal, oral, and rectal swabs inserted into the nose, mouth, and rectum, respectively. The swabs will be rubbed inside the cavity and then removed the swab. Oral and nasal swabs will also be collected in hospital (Cohort A, B) and at visits 3 and 12 months following hospitalization for (Long-term Outcomes Cohort). Rectal swabs will be collected in hospital only (Cohorts A, B).
- OTHER
-
Stool collection
Stool will be collected either in a cup after defecation or by collecting it from a tube or bag that may already be in place that is catching stool. Stool will be collected in hospital (Cohorts A, B) and at visits 3 and 12 months following hospitalization (Long Term Outcomes Cohort).
- OTHER
-
Heat Moisture Exchange Filter collection
An HME filter is a sponge that is placed in the tubing between a patient and breathing machine. It reduces the amount of heat and moisture a patient loses when on a breathing machine. Moisture from breath is collected in this filter. The filter is changed every few hours. When the filter is changed, it will be saved to collect the moisture that it contains and run tests on it. HME filters will be collected in hospital on intubated patients only (Cohorts A, B).
- OTHER
-
Tracheal Aspirate sample collection
Patients on a breathing machine have a breathing tube in their trachea that connects their lungs to the breathing machine. A smaller tube, called a suction catheter, will be placed through the larger tube and fluid will be gently sucked out. Tracheal aspirate will be collected in hospital on intubated patients only (Cohorts A, B)
- PROCEDURE
-
Non-bronchoscopic bronchoalveolar lavage (NBBAL)
The NBBAL procedure involves putting a flexible rubber tube through the breathing tube into the airway of one of the lungs. A small amount of fluid is injected into the lung and then a gentle suction is used to collect fluid. Only patients who pass a safety screen showing that they are not at high risk for complications will have the NBBAL procedure performed. NBBAL will be performed in hospital on intubated patients only (Cohort A)
- OTHER
-
Surveys
Participants will be contacted by email, text, and /or phone to give updates about their health. These surveys will ask questions about quality of life, mental health, return to work, and re-admission to the hospital. (Cohort A)
- OTHER
-
Short physical performance battery
At visits 3 and 12 months following hospitalization (Long-term Outcomes Cohort) Chair Stand Test: For this test the participant will sit in a chair. They will then stand as quickly as possible without using their upper body to assist them. Balance Test: For this test the participant will stand unsupported for 10 seconds with their feet in 3 different positions. 4-meter walk: For this test the participant will walk 4 meters as quickly as possible.
- OTHER
-
Hand grip strength
At visits 3 and 12 months following hospitalization (Long-term Outcomes Cohort): The participant will squeeze a machine called a hand-held dynamometer 3 times with all their strength.
- OTHER
-
CNS Vital Signs
At visits 3 and 12 months following hospitalization (Cohort A - Long-term Outcomes Cohort): The participant will sit at a computer and follow the prompts on the screen. This test takes about 45 minutes.
- OTHER
-
Muscle Ultrasound
At visits 3 and 12 months following hospitalization (Long-term Outcomes Cohort): The participant will undergo ultrasound on the quadriceps muscle on the dominant side of their body.
- OTHER
-
Muscle Strength
At visits 3 and 12 months following hospitalization (Long-term Outcomes Cohort): A dynamometer will be used to measure muscle strength in the dominant leg.
- OTHER
-
Spirometry
At a visit 12 months following hospitalization (Long-term Outcomes Cohort): The participant will have a clip placed on their nose and will be given a plastic mouthpiece that is connected to a machine called a spirometer. They will place their lips tightly around the mouthpiece and take in as big and deep of a breath as possible and then blow out as hard and fast as they can.
- OTHER
-
Lung Diffusion Testing (DLCO)
At a visit 12 months following hospitalization (Long-term Outcomes Cohort): The participant will have a clip on their nose. They will put their mouth over a mouthpiece that is attached to a machine. This machine will deliver a small amount of carbon dioxide when they breathe in and will also record the results of the test. They will then take a few normal breaths. Next they will inhale deeply and exhale completely. They will breathe in quickly through their mouth and hold their breath for 10 seconds or as long as they can. Then they will breathe out.
- RADIATION
-
Chest CT Scan
At a visit 12 months following hospitalization (Long-term Outcomes Cohort): The participant will undergo a Chest Computed Tomography (CT) scan which uses special X-ray equipment to take detailed pictures of the lungs.
Sponsors & Collaborators
-
Vanderbilt University Medical Center
lead OTHER
Principal Investigators
-
Wesley H. Self, MD, MPH · Vanderbilt University Medical Center
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-07-25
- Primary Completion
- 2029-04-30
- Completion
- 2029-04-30
Countries
- United States
Study Locations
More Related Trials
-
Biomarkers to Predict Acute Respiratory Distress Syndrome(ARDS) in Patients With Sepsis
NCT05914428 ·Status: UNKNOWN
-
Strain and Blood Inflammatory Markers as Prognostic Tools for ARDS AMIS (ARDS - Markers of Inflammation - Strain)
NCT02003326 ·Status: TERMINATED ·Phase: NA
-
Lung and Systemic Inflammation in the Critically Ill Patient
NCT01906229 ·Status: TERMINATED
-
Evaluating Health Outcomes and QOL After ALI Among Participants of the ALTA, OMEGA, EDEN, and SAILS ARDS Network Trials
NCT00719446 ·Status: COMPLETED
-
Research on Risk Assessment and Early Warning Models for Adverse Clinical Outcomes in Critically Ill Patients
NCT07317817 ·Status: COMPLETED
-
Clinical Features and Risk Factors Associated With Worse Outcome in Patients Hospitalized for Covid-19 Pneumonia
NCT04362345 ·Status: UNKNOWN
-
Clinical Features, Treatments, and Outcomes in Acute Respiratory Distress Syndrome (ARDS-CTO)
NCT07186140 ·Status: NOT_YET_RECRUITING
-
Establish a Prospective Registration System of ARDS Patients for Improving Quality of Care
NCT04032288 ·Status: COMPLETED
-
Compined SONOPULMONARY Infection Score and APACHE Score in RICU Patients With VAP
NCT06090032 ·Status: NOT_YET_RECRUITING
-
Large Observational Study to UNderstand the Global Impact of Severe Acute Respiratory FailurE
NCT02010073 ·Status: COMPLETED
-
Significance of Biological Markers in Patients With Acute Lung Injury/Acute Respiratory Disease
NCT00217880 ·Status: COMPLETED ·Phase: NA
-
Establishment of a Biomarkers-based Early Warning System of Acute Respiratory Distress Syndrome (ARDS)
NCT03236272 ·Status: UNKNOWN
-
Evaluating Artificial Intelligence-Based Clinical Decision Support for Sepsis and ARDS
NCT07025096 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
CTTI Risk Factors for HABP/VABP Study
NCT02689531 ·Status: COMPLETED
-
Ventilator-Associated Pneumonia in Critically Ill COVID-19 vs. Non-COVID-19 Patients
NCT05972980 ·Status: COMPLETED
-
Study of the Function of Cells Involved in Inflammation in the Lungs of Those With Acute Lung Injury and Sepsis
NCT01725061 ·Status: COMPLETED
-
Predicton of Sepsis Recovery Performance Subtypes Pilot Study
NCT05912413 ·Status: RECRUITING
-
The ASTERS Study: Assessing the Role of Sphingolipids in AcuTE Respiratory Distress Syndrome (ARDS)
NCT03654352 ·Status: COMPLETED
-
Early Biological and Mechanical Profiling in Sepsis-Associated ARDS
NCT07281911 ·Status: NOT_YET_RECRUITING
-
Study of Progression of Community Acquired Pneumonia in the Hospital
NCT02782013 ·Status: COMPLETED
-
Presepsin Biomarker for Ventilator-associated Pneumonia Diagnosis in COVID-19 Patients
NCT04840940 ·Status: UNKNOWN
-
Implementation of Lung Protective Ventilation in Patients With Acute Respiratory Failure
NCT03225807 ·Status: COMPLETED
-
Discovery of New Early Detection Biomarkers of Acute Respiratory Distress Syndrome
NCT02625064 ·Status: UNKNOWN
-
Serum Procalcitonin Study in the Management of Ventilated Patients
NCT00726167 ·Status: COMPLETED
-
Biomarker of Lung Injury in ARDS Patients Receiving ECMO Support
NCT01967602 ·Status: UNKNOWN